HTA Core Model_ Guiding principles on use
The HTA Core Model_Guiding principles on use_20151218
EUnetHTA-EMA f-t-f meeting summary 20150508, London, UK
Please find below the summary of the EUnetHTA / EMA face-to-face meeting, 8 May 2015, in London, UK. 2015-05-08 EMA-EUnetHTA – Meeting minutes – Final
EUnetHTA-EMA f-t-f meeting summary 20141209, Diemen, the Netherlands
Please find below the summary of the EUnetHTA / EMA face-to-face meeting, 9 December 2015 in Diemen, the Netherlands EMA EUnetHTA Diemen meeting Summary_Final_20150302
EUnetHTA Plenary Assembly 2015 – Summary report
EUnetHTA Plenary Assembly, 28-29 May 2015, Copenhagen, Denmark . Summary report and appendices. Find the full summary report below. Appendix A_20150528-29_EUnetHTA Plenary Assembly_FINAL Appendix B_SEED_Update on ED_for PA_2015 Appendix C_HTA NETWORK_EUnetHTA PA2015_Final Appendix D_EUnetHTA approach Spanish Network Appendix E_KCE national uptake core model Appendix F_Stakeholder Lessons learned Appendix G_Group 1 Appendix H_Group 2 Appendix I_Group […]
EUnetHTA methodological guideline – Methods for health economic evaluations
The methodological guideline on “Methods for health economic evaluations” was developed by WP7, Subgroup 3. The work with the present guideline was initiated to set a general framework for EUnetHTA on how to conduct economic evaluations as well as to increase the transferability of economic evaluations among EUnetHTA partners. This is especially important in order […]
EUnetHTA letter to the European Commission’s DG Research and Innovation on methodological issues of high importance
This letter from EUnetHTA to European Commission’s DG Research and Innovation, EUnetHTA outlines a number of methodological issues that are of high importance and which requires further research attention. EUnetHTALetter to DG RI on HTA in Horizon2020_final_20150312
EUnetHTA Evidence Submission Template
The EUnetHTA Submission Template is a flexible tool that reflects all national evidence requirements for reimbursement in Europe. The inclusion of all national requirements means that the template can be broadly applied to national and/or joint assessment. The adaptation process must include tailoring the tool’s content to either national HTA processes or joint processes to […]
EUnetHTA and MedTech industry expert meeting, summary of discussion
The meeting took place on October 16, 2015 at Eucomed / EDMA offices in Brussels, Belgium with participants coming from organisations-members of Eucomed, EDMA, COCIR (EUnetHTA Stakeholder Forum Members) and EUnetHTA. 20151016_EUnetHTA MedicalTechnology Expert meeting_SummaryFinal Anna Nachtnebel – MedTech Expert meeting 2015-10-16 Claudia Wild – MedTech Expert meeting 2015-10-16 François Meyer – MedTech Expert meeting […]
EUnetHTA / Medical Technology – HTA Expert meeting agenda, October 16, 2015
Draft agenda of the EUnetHTA / Medical Technology1 – HTA Expert meeting, October 16, 2015, in Brussels, Belgium. EUnetHTA-MedTech inudstry expert meeting – October 16 2015_Agenda
Endpoints used in Relative Effectiveness Assessment Surrogate Endpoints Amended JA1 Guideline Final Nov 2015
Endpoints used in Relative Effectiveness Assessment Surrogate Endpoints_Amended JA1 Guideline_Final Nov 2015
